Calquence 100 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9LK5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,685
Award facts
- Contract value 100% obligated
- $17,684.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,684.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg, a pharmaceutical product used in oncology treatment. The contract, awarded on January 15, 2026, with an ultimate completion date of February 6, 2026, represents a non-set-aside competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, demonstrates significant capability in fulfilling government healthcare supply needs through this award. The company's extensive portfolio of federal contracts encompasses a comprehensive range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. The Cencora IDC with DLA enables flexible procurement of essential pharmaceutical commodities required by military treatment facilities and veterans' healthcare programs, positioning the contractor as a key supplier within the Defense Health Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9LK5?
SPE2DR26F9LK5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9LK5 worth?
The government has obligated $17,685 on SPE2DR26F9LK5.
Is contract SPE2DR26F9LK5 an order under another contract?
Yes. SPE2DR26F9LK5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LK5 competed?
The extent of competition for SPE2DR26F9LK5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award